Thumbnail Image
Publication

Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC).

Fish, Rebecca
; 
Sanders, C
; 
Ryan, N
; 
der Veer, S
; ; 
Williamson, P
Citations
Altmetric:
Abstract
Six Phase III randomized trials have determined the effectiveness of chemoradiotherapy as primary treatment for anal squamous cell carcinoma (ASCC), but outcomes reported in these trials varied widely, hindering evidence synthesis. To improve reporting in all future trials, we aim to develop a core outcomes set (COS). As the first stage of COS development, we undertook a systematic review to summarize the outcomes reported in studies evaluating chemoradiotherapy for ASCC.
Authors
Fish, Rebecca
Sanders, C
Ryan, N
der Veer, S
Renehan, Andrew G
Williamson, P
Affiliation
Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Vaughan House, Portsmouth Street, Manchester, M13 9GB
Description
Date
2018-05
Publisher
Collections
All Christie Publications
Show all metadata
Files
Thumbnail Image
Open access full text article
Adobe PDF, 343.36 KB
Keywords
Type
Article
Citation
Systematic review of outcome measures following chemoradiotherapy for the treatment of anal cancer (CORMAC). 2018, 20(5): 371-382 Colorectal Dis
Journal Title
Journal ISSN
Volume Title
URI
http://hdl.handle.net/10541/620983
Embedded videos